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properties exert their growth modulatory effects
indirectly via receptor-mediated mechanisms,
leadingtoaberrantproliferation andbreastcancer.
Source: Davis DL, Telang NT, Osborne MP, Bradlow HL. Medical
hypothesis: bifunctional genetic-hormonal pathways to breast cancer.
Environ Health Perspect1051suppl3):571 576(19971
the development of this disease, the most
common cancer among women. An October
1993 petition signed by 2.6 million people
asked President Clinton for a newstrategyto
fight breast cancer. This petition led to the
development ofthe National Action Plan on
Breast Cancer (NAPBC). The Etiology
Working Group of the NAPBC, together
with the National Cancer Institute, Tulane
University's Center for Bioenvironmental
Research, and the U.S. Public Health
Service's Office of Women's Health con-
vened a workshop on hormones and breast
cancer 28-29 September 1995. Selected
papers from this workshop, as well as some
response papers, form the basis ofHormones,
HormoneMetabolism, andBreast Cancer.
Modern epidemiological studies have
found that most of the known risk factors
for breast cancer, excluding radiation, are
directly related to lifetime exposure to estra-
diol and other hormones. Researchers have
reasoned that any environmental chemical
that has the ability to mimic human hor-
mones or affect their metabolism may be
carcinogenic. However, some xenohormones
(such as DDT) appear to be harmful, while
others (such as phytoestrogens) appear to be
protective. The mechanisms by which xeno-
hormones influence bodily processes, poten-
tially leading to cancer, have not been deci-
sively identified. The papers presented in
Hormones, Hormone Metabolism, and Breast
Cancercontribute to elucidating these mech-
anisms and differentiating among helpful
and harmful hormones.
The monograph also includes views and
concerns of some breast cancer research
advocates. For example, Sandra Steingraber
ofthe Women's Community Cancer Project
writes about her concern that more work is
being done to identify the mechanisms of
cancer than is beingdone to protect thepub-
lic from the disease. "We are interested in
research that identifies breast carcinogens,
and we [are also] interested in social changes
thatwould keep these agents out ofwomen's
breasts in the first place," says Steingraber. In
another paper, Craig Dees ofthe Oak Ridge
National Laboratory and colleagues propose
that the colorant Red Number 3 causes
genetic damage and could be a significant
riskfactor for breast cancer.
Other researchers present additional sup-
port for a link between sex hormone levels
and breast cancer incidence. One nested
case-control study by Joanne F. Dorgan of
the National Cancer Institute and colleagues
examines serum estrogen levels and cancer
incidence in postmenopausal women.
Another paper finds that dietary estrogens at
low concentrations can stimulate human
breast cells to begin replication. In a paper
by Ruth H. Allen of the National Cancer
Institute and colleagues, the relationship
between increasing breast cancer incidence
amongwomen in Hawaii and the use ofpes-
ticides there provides evidence of a link
betweenxenohormones and cancer risk.
Research on the link between
known risk factors for breast
cancer and lifetime expo-
sure to bioavailable
estradiol has led to the
idea that xenohor-
mones can affect the
body by two dis-
tinct paths, either
by attacking DNA
directly orby inter-
actingwith endoge-
nous hormones and
altering the forma-
tion of hormone
metabolites. A paper by
Takeki Tsutsui of the _
Nippon Dental University and
colleagues found evidence of DNA
adduct formation and aneuploidy induction
(precursors to cancer) in response to estro-
gen. The mechanism by which phytoestro-
gens maywork to prevent cancers is discussd
in Hormones, Hormone Metabolism, and
Breast Cancer, and monograph authors sug-
gest that these chemicals act to reduce the
binding of other xenoestrogens to human
estrogen receptors. It is also suggested in the
monograph that the presence or absence of
lipophilic regions on estrogens and xenoe-
strogens mayaffect their binding characteris-
tics and cold be used to distinguish harmful
estrogens from beneficial ones.
The papers presented in Hormones,
HormoneMetabolism, andBreast Canceralso
discuss ways of measuring human hormone
levels as a means ofassessing an individual's
risk ofdeveloping breast cancer. Researchers
compared the sensitivity of two competing
methods ofmeasuring hormone metabolites
(2-hydroxyestrone and 16a-hydroxyestrone
immunoassays) and found a high degree of
agreement for premenopausal women, a
finding that could lead to more refined
methods of measurement. Other authors
identified ways to measure xenoestrogen lev-
els in human serum. According to Devra
Davis, program director of the Health,
Environment, and Development Program of
the World Resources Institute and an editor
of the monograph, better methods of mea-
suring hormone levels will make it easier for
scientists to identify environmental carcino-
gens. "Experimental methods for identifying
hazards need to be developed, and measur-
ing [xenohormone] levels present [in the
body] is a very direct way ofassessing expo-
sure." Davis said that future research should
concentrate on these issues.
New Dimensions to Dementia
Two studies published last September pro-
vide new clues to possible links between
environmental factors and neurode-
generative diseases. Both genetic
and environmental factors
are thought to play a role
in the development of
such diseases. How-
ever, until now,
C"more progress has
been made on the
genetic side of the
equation," says
George Martin, dir-
i,
I_d. ector of the Alzhei-
mer's Disease Research
Center at the University
ofWashington in Seattle.
These studies and others like
them are the latest attempts to
rectifythat imbalance.
The first study, published in the 25
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September 1996 issue of the Journal ofthe
American MedicalAssociation ([AMA), esti-
mated the prevalence oftwo major types of
dementia-Alzheimer's disease and vascular,
or stroke-related, dementia-in about 3,700
Japanese-American men over age 70. These
men are surviving members ofthe Honolulu
Heart Program, a longitudinal study that
began in 1965 to investigate cross-cultural
differences in heart disease. AR ofthe sub-
jects lived in Hawaii atthestudy's outset.
Based on past reports, Alzheimer's dis-
ease is the predominant type ofdementia in
Western nations, while vascular dementia is
predominant in Japan. "In our study, the
men had almost as much vascular dementia
as is found inJapanese men living inJapan,"
says Helen Petrovitch, an associate professor
ofmedicine at the University ofHawaii and
coauthor of the study. "However, they also
had Alzheimer's disease at a rate almost
equal to what is seen in the United States. It
appears that something about moving from
Japan led to an increase in Alzheimer's dis-
easeprevalence."
Martin calls the paper a landmark study
andsays thatthese data arethe bestyet avail-
able on whether the introduction of a new
environment can make a difference in the
occurrence ofAlzheimer's disease. "The
question for the future," says Martin, "is
what factor in the environment is leading to
more Alzheimer's. It is an extraordinarily
important question, because ifyou can iden-
tify some contributing factor in the environ-
ment, then you may be able to use this
knowledge to postpone thedisease."
TheJAMA study has been criticized for
relying on comparisons among prevalence
studies that used slightly different diagnostic
criteria. The diagnosis ofAlzheimer's disease
is notoriouslytricky. Adefinitediagnosis can
only be made after death by autopsy ofthe
brain. The clinical diagnosis ofAlzheimer's
disease in living patients is much more sub-
jective. "When we make comparisons
among surveys conducted by various
researchers, part ofthe reason we find preva-
lence differences may be that the disease was
just defined differently," says Petrovitch.
This problem is now being addressed in
ongoing research. "We have sister centers in
Japan, Seattle, and Taiwan, and we're stan-
dardizing our diagnostic criteria and meth-
ods at all these sites," Petrovitch says. The
results are expected to be available within a
year. When theyare, scientists should have a
better base for comparing Alzheimer's dis-
ease acrosscultures.
A second study on a related topic
appeared in the September 1996 issue ofthe
American Journal of Public Health.
Researchers in this study examined the
occurrence of four neurodegenerative dis-
eases-Alzheimer's disease, presenile demen-
tia, Parkinson's disease, and motor neuron
disease-among members ofvarious occu-
pations. Lead author Paul Schulte, an epi-
demiologist at the National Institute for
Occupational Safety and Health, and his
colleagues examined death certificates from
27 states for the period 1982-1991. They
looked fordeath certificates where one ofthe
diseases was mentioned as either the main
cause or a contributing cause ofdeath. They
also noted the occupations listed on those
certificates.
The researchers then compared the actu-
al proportion ofdeaths from a specific dis-
ease within a particular occupational group
to the expected proportion-the proportion
of deaths from that disease in all occupa-
tions. In a number ofcases, the actual pro-
portion exceeded the expected proportion by
a statistically significant amount. More
deaths than expected from all four diseases
were found for teachers, medical personnel,
machinists and machine operators, scientists,
writers, designers, entertainers, and support
and clerical workers. Excessive death rates
from some diseases were also found for peo-
ple with jobs involving pesticides, solvents,
and electromagnetic fields. The bottom line,
says Schulte, is that "these neurodegenerative
diseases don't appear to
be occurring randomly,
but occur more fre-
quently in some occu-
pations than inothers."
"This is just a pre-
liminary investigation,"
cautions Schulte. In
fact, there are serious
limitations to the study.
For one thing, death
certificates provide only
a rough measure ofdis-
ease occurrence and
usual occupation, and
no information at all
about other occupations
and risk factors. Also,
this type ofstudydesign
is not able to clarify
cause-and-effect rela-
tionships. The value of
studies such as this one,
Schulte says, "is [in]
generating leads for
future research."
"This kind ofstudy
is the very first step in a
series ofepidemiologic
inquiries," says Gwen
Collman, an environ-
mental epidemiologist
at the NIEHS. The
JAMA study, with its
more sophisticated design, is a few steps far-
ther along the trail. However, both studies
are still some distance from showing which
environmental factors are critical to the
development ofneurodegenerative diseases
so that such information may be used to
postpone orprevent these illnesses.
The Arctic Council
"The Arctic is an early warning system for
our planet," said Sergio Marchi, Canadian
minister ofthe environment, speaking at the
19 September 1996 inauguration of the
Arctic council. The council is an intergov-
ernmental forum designed to build consen-
sus on issues ofenvironment and sustainable
development, as well as monitor pollution,
disseminate information, andpromote coop-
eration among the eight Arctic nations and
theirindigenous populations.
The Arctic Council evolved from the
Arctic Environmental Protection Strategy
(AEPS), established in 1991 to deal with the
threat ofpolar pollution. In the summer of
1997, the Arctic Council will take over the
work of the AEPS. Specifically, four com-
mittees of the AEPS will continue to work
through the Arctic Council. The Arctic
Monitoring and Assessment Program
Weighty issues. The newly established Arctic Council will deal with issues
such as chemical contamination, sustainable development, and endan-
gered species.
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